Mesirow Financial Investment Management Inc. Purchases New Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Mesirow Financial Investment Management Inc. acquired a new position in Addus HomeCare Co. (NASDAQ:ADUS) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,264 shares of the company’s stock, valued at approximately $234,000.

A number of other institutional investors have also recently bought and sold shares of the business. Principal Securities Inc. bought a new position in Addus HomeCare during the fourth quarter valued at about $26,000. GAMMA Investing LLC purchased a new stake in shares of Addus HomeCare during the 4th quarter worth approximately $34,000. Assetmark Inc. raised its holdings in shares of Addus HomeCare by 33.3% in the 4th quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after purchasing an additional 443 shares during the period. Envestnet Portfolio Solutions Inc. purchased a new position in Addus HomeCare in the fourth quarter valued at approximately $214,000. Finally, Cetera Trust Company N.A bought a new position in Addus HomeCare during the fourth quarter valued at $219,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS traded up $0.73 during trading on Wednesday, reaching $117.38. The company had a trading volume of 104,242 shares, compared to its average volume of 132,487. The company has a fifty day moving average of $110.60 and a two-hundred day moving average of $100.28. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $1.92 billion, a P/E ratio of 28.95, a price-to-earnings-growth ratio of 1.77 and a beta of 1.01. Addus HomeCare Co. has a 12 month low of $78.35 and a 12 month high of $120.53.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a return on equity of 10.03% and a net margin of 6.04%. The business had revenue of $280.70 million for the quarter, compared to analysts’ expectations of $279.49 million. During the same quarter in the prior year, the firm earned $0.84 earnings per share. The firm’s revenue was up 11.6% on a year-over-year basis. Equities research analysts forecast that Addus HomeCare Co. will post 4.36 earnings per share for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 4.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Bank of America boosted their target price on Addus HomeCare from $115.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, May 7th. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective on the stock. in a report on Tuesday, April 23rd. Stephens boosted their price target on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an “overweight” rating in a research report on Friday, May 31st. Macquarie began coverage on shares of Addus HomeCare in a report on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective for the company. Finally, Oppenheimer raised their target price on Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research note on Friday, June 7th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $116.25.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.